Amarin Corp Plcuk (AMRN) Total Liabilities (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Total Liabilities of $196.4 million for Q1 2026, up 7.89% year-over-year from $182.0 million in Q1 2025, and down 7.16% quarter-over-quarter from $211.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Total Liabilities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Total Liabilities data on file, last reported at $196.4 million in Q1 2026.

  • Total Liabilities for Q1 2026 came in at $196.4 million, up 7.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $196.4 million (up 7.89% YoY), and the FY2025 annual result was $211.5 million, up 6.19% from the prior year.
  • Total Liabilities fell to $196.4 million in Q1 2026 per AMRN's latest filing, from $211.5 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $393.2 million in Q2 2022 and troughed at $182.0 million in Q1 2025.
  • A 5-year average of $257.4 million and a median of $248.0 million in 2024 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Total Liabilities declined 28.76% in 2024, then grew 7.89% in 2026.
  • A 5-year view of Total Liabilities shows it stood at $290.8 million in 2022, then decreased by 3.87% to $279.6 million in 2023, then decreased by 28.76% to $199.2 million in 2024, then grew by 6.19% to $211.5 million in 2025, then declined by 7.16% to $196.4 million in 2026.
  • Business Quant data shows AMRN's Total Liabilities at $196.4 million in Q1 2026, $211.5 million in Q4 2025, and $200.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -61.27 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 85.38 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 119.71 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 143.08 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 82.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 83.31 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 32.76 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 117.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 66.37 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 196.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 196.35 Mn
Dec 31, 2025 211.49 Mn
Sep 30, 2025 200.92 Mn
Jun 30, 2025 205.20 Mn
Mar 31, 2025 181.99 Mn
Dec 31, 2024 199.17 Mn
Sep 30, 2024 219.24 Mn
Jun 30, 2024 247.98 Mn
Mar 31, 2024 244.08 Mn
Dec 31, 2023 279.59 Mn
Sep 30, 2023 285.88 Mn
Jun 30, 2023 290.89 Mn
Mar 31, 2023 275.40 Mn
Dec 31, 2022 290.85 Mn
Sep 30, 2022 320.48 Mn
Jun 30, 2022 393.19 Mn
Mar 31, 2022 332.60 Mn
Dec 31, 2021 400.97 Mn
Sep 30, 2021 393.31 Mn
Jun 30, 2021 399.67 Mn